Abstract
540P Phase III study of serplulimab plus chemotherapy as first-line therapy for advanced squamous non-small cell lung cancer: ASTRUM-004 Asian subgroup
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have